Podcasts about bioengineering

Dr. Jin Hyung Lee is an electrical engineer focused on understanding the circuits of the human brain and how they relate to brain disorders. She is an associate professor of Neurology, Neurosurgery, Bioengineering, and Electrical Engineering at Stanford University. Her work with LVIS has led to the creation of NeuroMatch which focuses on mapping the brain to help with diagnosing brain disorders and creating new treatments for brain issues.    You can following the work of LVIS at: https://lviscorp.com/en/ Follow on YoutTube at: www.youtube.com/@LVISNeuroMatch Follow Dr. Jin on X @ljinhy   Mental Maps is brought to up by Arukah Well. Learn more at www.arukahwell.co    

Research in the past has indicated that neurological disorders such as Alzheimer's disease are non-infectious. But what if it was possible to catch a brain infection? Joining us to discuss this fascinating topic is Dr. Or Shemesh, an expert working to build and utilize new technologies to study and reverse brain disease… Dr. Shemesh is an Assistant Professor at the University of Pittsburgh School of Medicine, Departments of Neurobiology and Bioengineering. Here, he works in a cutting-edge field called “Counter Disease Engineering” – otherwise known as a technological approach to understanding diseases of the nervous system.  In this conversation, we cover: The major causes of inflammation. The unique connection between nervous system diseases and infectious agents.  How microbes impact our overall health.  How brain pathogens are potentially connected to Alzheimer's.  You can learn more about Dr. Shemesh and his work here! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

In this episode, we discuss the anti-aging effects of therapeutic plasma exchange (TPE) with Dr. Irina Conboy, a professor in the Department of Bioengineering at UC Berkeley. Her current research focuses on unraveling the key signal transduction pathways that regulate adult stem cell behavior – and understanding how these pathways change with age… From synthetic biology to CRISPR technologies, Dr. Conboy has been working in the fields of aging and genetic diseases for decades. Is aging a disease that can be solved? If so, what role does TPE play in it? If you're interested in the mysterious topic of human aging, this podcast is undoubtedly for you! Jump in to find out: What TPE is, and what it's used for.  The benefits of “rebooting” blood signal proteins. What blood plasma is, and how it is produced in the human body. How TPE is linked to anti-aging.   You can follow along with Dr. Conboy and her lab's work here. Episode also available on Apple Podcasts: http://apple.co/30PvU9C

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

The 3rd Annual Global Astrobiotechnology Hub focuses on advancing the intersection of space exploration, biotechnology, and innovation. The program brings together scientists, researchers, and space professionals to discuss how space technologies can accelerate scientific breakthroughs, particularly in fields like personalized medicine and bioengineering. Key themes include the challenges of conducting real-time research in space, the need for specialized astronaut-scientists, and the potential of space for groundbreaking experiments, such as organoid growth and in-space manufacturing. Experts underscore the importance of public access to scientific data and highlight the role of new media in engaging the public with space research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40389]

Andy Constan stops by to discuss today's US macro backdrop. Importantly, this discuss was recorded on 4/24. Since then the narrative around the tax bill has gotten incrementally more stimulative. Do what you will with that information.Bill reached out to Andy after following him for a while on Twitter. Andy appears to use Twitter to educate, inform, and journal thoughts. Hence why he was invited to the show.As for Andy's formal background, his bio reads as follows:Andy Constan graduated with a degree in Bioengineering from the University of Pennsylvania in 1986.Following he spent 35 years investing and trading global equities, spending 17 years at Salomon Brothers.Following he started honing his Macroeconomic Knowledge in 2010 working at Bridgewater Associates and Brevan Howard.Since then he has worked on growing Damped Spring Advisors.We hope you enjoy the conversation.

Caolan Kelly joins me this week to share his story of feeling stuck and unfulfilled in his life and work. I loved Caolan's passion and energy for how he is living his life now and helping others to reach their full potential. He has faced his own challenges in life, but through them he has become even more resilient and even took on the challenge of walking along across Europe - over 1600km to raise awareness for a Mental Health and the supports that are available to all. After earning his MSc in BioEngineering and spending years in the corporate world, He realised he was chasing the wrong dream. He took a leap - ditching the 9-5 to build his own personal brand. In just 10 months he built an engaged audience of 15K across platforms using the power of storytelling. Now he helps businesses to master the untapped potential through his StorySelling framework - teaching you how to turn your story into your most powerful asset, build industry authority and win clients. He is on a mission to help 500 plus businesses capitalise on this rare window of opportunity. How can your origin story connect? What is our why? What was the defining moment you created or started your business? How can you inspire others? Are you ready to step out of your comfort zone? What is your vision? How can you connect with your audience on a deeper level? Thanks for listening to Sharon's podcast. Subscribe for free to receive new posts and support my work.Let Caolan guide you - Contact him today! https://www.instagram.com/kelly_caolan/ https://www.linkedin.com/in/caolankelly55/ https://www.youtube.com/ ⁨@CaolanKelly⁩ This podcast is proudly partnered with https://intothewestadventures.com/ This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit sharonfitzmaurice.substack.com

Join T, Father Fortenberry, Gary and Marty Mar the Bourbon Nerd as they discuss headlines of the day. Momfluencers gone wild - what will they not do for $$$Bioengineering - What is a Wolly Mouse and why should be care?The empire strikes back - and we are not talking about the Trade war, or are we? All that and much more on today on the Patio!Buy some Merch:https://lifefromthepatio.com/merchfollow us on TikTok:https://tiktok.com/@lifefromthepatio2 #bourbon #whiskey #fye #KnobCreek#Jack Daniels#comedy #podcast#funnyvideo #buffalotrace #distillery#buffalo #LFTP#oldforester #jimbeam #heavenhill#Bluenote#Shortbarrel#rye #ark #arknights#arkansas #nba #nfl #razorbacks #newyears #resolutions#LFTP Fred Minnick

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Philip Lee, CEO at GeneFab. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Philip, covering: The role of luck in the development of his entrepreneurial journey of multiple biopharma start-ups Bootstrapping a biological tech company and then selling to Millipore, along with lessons learnt from a more prominent global organization Building a new company from the back of a napkin to an IPO on the NASDAQ Creating a technology platform and operational capability with real therapeutic application that led to the spin-out of Genefab Bridging the gap for early-stage cell therapy companies with aligned incentives and a non-transactional model Philip Lee is a bioengineer, biotechnology entrepreneur, and executive who has spent the last 20 years building companies and commercializing products, including cell and gene therapies, synthetic biology platforms, scientific instrumentation, cell culture systems, and advanced manufacturing services. He has been the “first employee” at multiple ventures with leadership experience across diverse growth trajectories, including bootstrapping, VC and PE funding rounds, IPO, acquisition, and internal innovation within a large enterprise. Philip holds degrees from the Massachusetts Institute of Technology and the UC Berkeley/UCSF Joint Graduate Program in Bioengineering. Philip is currently the founding CEO of GeneFab, a contract research, development, and manufacturing organization focused on supporting its clients in bringing innovative genetic medicines to needy patients.  Before GeneFab, Philip was the Co-Founder and CTO of Senti Biosciences, a cell and gene therapy company applying gene circuit technology to improve the efficacy and safety of cancer cell therapies. Philip was also the co-founder and CEO of Cellasic Corp, a microfluidics instrumentation company that MilliporeSigma had acquired. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

Listen to this episode if you: are an early career engineer, are contemplating a career change, or just like engineering career stories.This Week in LinkedIn Lunatics:⁠⁠1. Still in college but ready to strangle my friend who said this yesterday

Cara Bognar is the Founder of Top Tier Lessons, a sports technology platform that connects collegiate student athletes with parents looking for sports lessons for their children.  She's an athlete herself, as a former team captain for Illini Swimming & Diving, and graduated from UIUC with dual degrees in Bioengineering and Innovation Leadership and Engineering Entrepreneurship (ILEE).Cara's LinkedIn- https://www.linkedin.com/in/carabognar/Top Tier Lessons- https://www.toptierlessons.com/VISIT http://researchpark.illinois.edu/podcast/ for our entire catalog of episodes.

In this episode, I talked to Dr. Karolina Valente, CEO of Voxcell BioInnovation. Dr. Valente talks about how her company, Voxcell, is trying to revolutionize the drug development process by developing customizable 3D tissue models to test different therapeutics and drugs. We also talked about how AI will affect future drug trials, Vancouver's potential as a biotech hub, improvements needed to strengthen Canada's biotech industry, Voxcell's new and old products, and the difficulty of raising money to go to different rounds. ---------------------------------------------------------------Thanks to the sponsors:Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoatNewsly: https://newsly.mepromo code to receive a 1-month free premium subscription: EARLYMORNING Libysn: https://libsyn.compromo code: DG Dubby Energy: https://www.dubby.ggpromo code for 10% off: DIAMONDGOATOpus Clips:  https://www.opus.pro/?via=diamondgoat----------------------------------------------------------------------------------Listen on:Podcast website: https://www.spreaker.com/podcast/dg-early-morning-show--5943922Spotify: https://open.spotify.com/show/0EuhA6WyuerHtVAqcFrFeOPodcast YT channel clips: https://www.youtube.com/@dgearlymorningshowTiktok: @dgearlymorningshowApple Podcast: https://podcasts.apple.com/us/podcast/dg-early-morning-show/id1575451533Amazon Music: https://music.amazon.com/podcasts/f050b86c-1dad-4bc3-b12f-6aa5fa62438c  Goodpods: https://goodpods.com/podcasts/dg-early-morning-show-211830RadioPublic: https://radiopublic.com/dg-earlymorning-show-WoML4rBreaker: https://www.breaker.audio/dg-early-morning-showReason: https://reason.fm/podcast/dg-earlymorning-show--------------------------------------Check out my other stuff:Instagram: @itzdiamondgoatTwitter: @lildiamondgoatMain YT channel: youtube.com/diamondgoatTiktok: @lildiamondgoatSoundcloud: @Lil DiamondgoatSpotify: @Lil DiamondgoatMerch store: https://diamondgoat.creator-spring.com

London scientists have developed a new material called Roliner which allows amputees to adjust the fit of prosthetic limbs.Our bodies change shape during the day which can be uncomfortable for amputees if their prosthetics don't fit properly.To find out more, we're joined by Professor Firat Guder from Imperial's Department of Bioengineering, one of the researchers behind Roliner. Also in this episode:Spring Statement: Rachel Reeves says £400m will be allocated to 'bring innovative technology to the front line'Could Trump cut tariffs on China to complete a TikTok deal?Why social media has been flooded with Ghibli-style AI-generated imagesAbba ‘adding a little something' to their avatar arena showsLucky! Two medieval rings found by metal detectorists sell at auction for… Hosted on Acast. See acast.com/privacy for more information.

The Soil Matters with Dr. Gerald PollackSeason 3, Episode 07 Today's Guest: Dr. Gerald PollackGerald Pollack received his PhD in biomedical engineering from the University of Pennsylvania in 1968. He then joined the University of Washington faculty and is now professor of Bioengineering. He is also Founding Editor-in-Chief of the journal, WATER, convener of the Annual Conference on the Physics, Chemistry and Biology of Water, and Executive Director of the Institute for Venture Science. His interests have ranged broadly, from biological motion and cell biology to the interaction of biological surfaces with aqueous solutions. His 1990 book, Muscles and Molecules: Uncovering the Principles of Biological Motion, won an “Excellence Award”from the Society for Technical Communication. His 2001 book, Cells, Gels and the Engines of Life, and his newest book, The Fourth Phase of Water: Beyond Solid, Liquid,and Vapor won that Society's “Distinguished Award,”their highest distinction. The latter book went on to receive the World Summit Excellence Award. Pollack received an honorary doctorate in 2002 fromUral State University in Ekaterinburg, Russia, and was more recently named an Honorary Professor of the Russian Academy of Sciences, and foreign member and Academician of the Srpska Academy. He received the Biomedical Engineering Society's Distinguished Lecturer Award in 2002. In 2008, his colleagues chose him as the recipient of his university's highest annual distinction: the UW Faculty Lecturer Award. Pollack is a Founding Fellow of the American Instituteof Medical and Biological Engineering and a Fellow of both the American Heart Association and the BiomedicalEngineering Society. He received an NIH Director's Transformative R01 Award. He was the 2012 recipient of the Prigogine Medal for thermodynamics of dissipative systems,and in 2014 he received the Scientific Excellence Award from the World Academy of Neural Therapy, as well as the Dinsdale Prize from the Society for Scientific Exploration.He has presented two TEDx talks on water. In 2015, he won the BrandLaureate Award, previouslybestowed on notables such as Nelson Mandela, Hillary Clinton and Steve Jobs. In 2016 he was awarded the EmotoInaugural Peace Prize, and more recently the LifetimeAchievement Award from the Chappell Natural Philosophy Society. He appears briefly in the 2016 Travis Rice sports-action film, The Fourth Phase, named after his recentbook. And, he is included in the 2019 listing, OOOM Magazine, as one of the “World's 100 Most Inspiring People.” In 2020, he presented his work at the “Majlis” by invitation from the Crown Prince of Abu Dhabi at his Royal Palace, and more recently, in 2023, at the United Nations. Your Host: Leighton Morrisonhttps://www.instagram.com/kingdomaqua... https://www.kingdomaquaponicsllc.com/  Executive ProducerKen Somerville https://www.instagram.com/kensomerville/ https://www.itsallaboutthebiology.ca Contact emailitsallaboutthebiology@gmail.com Reach out to Ken for a quick 15 mincall:https://calendly.com/kensomerville/connections Help to support the mission: patreon.com/user?u=104510089 Discount codes available at: https://www.itsallaboutthebiology.ca/discountcodes #flowers,#plants,#nature,#gardening,#garden,#growing,#koreannaturalfarming,#naturalfarming,#jadam,#naturalfertilizer,#naturalfarminginputs,#permaculture,#regenerative,#foodforest,#biodynamic,#bioactive,#organic,#notill,#knf,#organicgardening,#urbangardening,#containergardening,#homegardening, Music by The Invisible Gardener (Andy Lopez) https://soundcloud.com/invisiblegardenerFor Full: Disclaimer

Richard Gaster, M.D., Ph.D., is a Managing Partner at venBio with experience as a physician, entrepreneur, and life science investor. Now, a cancer dad. He has helped to launch, invest, and serve on the board of or as board observer of a number of venBio companies. Prior to joining venBio, Dr. Gaster served as the head of translational medicine at Pliant Therapeutics. As a key member of the founding management team, Dr. Gaster was instrumental in the formation and launch of Pliant Therapeutics from Third Rock Ventures where he previously served as a Senior Associate.Dr. Gaster has published numerous articles in top-tier peer-reviewed journals including Nature Medicine and Nature Nanotechnology, holds more than a dozen patents, was awarded first prize in the IEEE Change the World Competition, and was named one of Forbes “30 Under 30” in Science and Healthcare.Dr. Gaster holds a B.S.E in Bioengineering from the University of Pennsylvania where he graduated summa cum laude and was a University Scholar. He received his M.D. and Ph.D. in Bioengineering from Stanford University in the Medical Scientist Training Program.On March 1, 2024, my daughter, Claire experienced a seizure. She was diagnosed with a type of brain cancer called AT/RT (atypical teratoid rhabdoid tumor), a highly aggressive grade IV glioma..... tune in for the rest of the story!You can also get involved with the Gold Ribbon Kids Cancer Foundation or the National Pediatric Cancer Foundation through fundraising, volunteering, promoting awareness, or contributing to pediatric cancer research. Visit goldribbon-kids.org or nationalpcf.org for more informationTo contact Tiffany, please email info@goldribbon-kids.orgTo contact Kelly, please email kgoddard@nationalpcf.orgSupport the show

In this episode, I chatted with Dr. Kaitlyn Sadtler, who is pushing the boundaries of biomedical science. Co-hosted with HHMI Gilliam Fellow and ChemE PhD Candidate Sydney Floryanzia, we talk about their groundbreaking research, the twists and turns of their scientific journeys, and the power of collaboration in tackling big challenges.More on Dr. Sadtler, per the NIBIB:Kaitlyn Sadtler, Ph.D. joined NIBIB as an Earl Stadtman Tenure-Track Investigator and Chief of the Section for Immunoengineering in 2019. Prior to her arrival to the NIH, she completed a postdoctoral fellowship at the Massachusetts Institute of Technology with Daniel Anderson, Ph.D. and Robert Langer, Ph.D., focusing on the molecular mechanisms of medical device fibrosis. During her time at MIT, Dr. Sadtler was awarded an NRSA Ruth L Kirschstein Postdoctoral Fellowship, was listed on BioSpace's 10 Life Science Innovators Under 40 To Watch and StemCell Tech's Six Immunologists and Science Communicators to Follow. In 2018, she was named a TED Fellow and delivered a TED talk which was listed as one of the 25 most viewed talks in 2018. She was also elected to the 2019 Forbes 30 Under 30 List in Science, selected as a 2020 TEDMED Research Scholar, and received multiple other awards. Dr. Sadtler received her Ph.D. from the Johns Hopkins University School of Medicine where her thesis research was published in Science magazine, Nature Methods, and others. She was recently featured in the Johns Hopkins Medicine Magazine as an alumna of note. Dr. Sadtler completed her bachelor's degree summa cum laude at the University of Maryland Baltimore County, followed by a postbaccalaureate IRTA at the Laboratory of Cellular and Molecular Immunology at NIAID.

Can bioengineering and stem cell therapy revolutionize healthcare by focusing on prevention and regeneration rather than just treating symptoms? What if medical science could restore vitality and longevity at the cellular level? In this episode, we sit down with Kevin Caldwell, CEO, Co-Founder, and President of Ossium Health, to explore these game-changing advancements… Ossium Health is a pioneering bioengineering company that leverages organ donor bone marrow banking to develop cutting-edge stem cell therapies. These treatments offer new hope for patients battling life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal disorders. What started as a small startup has grown into a clinical-stage company on a mission to transform regenerative medicine and improve human health. Join us as we discuss: How Kevin's shift in mindset led to the creation of Ossium Health Why modern healthcare struggles with chronic disease management How stem cell therapy is revolutionizing treatment for immune and blood disorders The critical role of cell composition in successful organ transplants Before launching Ossium Health, Kevin worked as an Engagement Manager at McKinsey's San Francisco office, guiding biotech and healthcare companies through market expansion, revenue growth, and strategic restructuring. Now, he's applying that expertise to develop innovative stem cell solutions that could redefine modern medicine. Ready to discover the future of regenerative healthcare? Visit Ossium Health now! Episode also available on Apple Podcasts: https://apple.co/38oMlMr

In this episode, Dr. Joe Casciani is joined by Jennifer Morrison, an expert in vehicle safety at Mazda. Together, they explore the evolving landscape of automotive safety, with a focus on how advanced car technologies can help prolong senior independence. They discuss critical safety features, the importance of behavioral safety, and recommendations for selecting the safest vehicles for older adults. The conversation also touches on car safety ratings, electronic system familiarity, and the potential future of driverless vehicles. Jennifer shares insights on the latest crash avoidance and crash-worthiness features. They also discuss their perspectives on maintaining confidence in driving as we age. The episode concludes with a discussion on the future of autonomous vehicle technology and driverless taxi programs. What are their implications for senior mobility? Mini Bio Jennifer Morrison oversees vehicle safety strategy and communications for Mazda North American Operations. She is responsible for compliance with federal safety regulations, crash testing and consumer rating programs, and the thoughtful deployment of advanced driver assistance technologies for all US vehicles. Jennifer started her career in transportation safety in the Office of Defect Investigations at the National Highway Traffic Safety Administration (NHTSA). She then spent 15 years as a Vehicle Factors Investigator and Investigator-in-Charge at the National Transportation Safety Board (NTSB) where she investigated over 70 major crashes involving trucks, buses, cars, and trains. The experience turned her into a dedicated safety advocate, focusing on collision avoidance, vehicle crashworthiness, and data-driven improvements to transportation safety. Jennifer has degrees in Bioengineering from the University of Pennsylvania and Applied Automotive Technology from Montgomery College. She has held various leadership positions within Washington, DC based automotive industry groups, including the Alliance for Automotive Innovation and the SAE Washington DC Section, where she mentors and connects automotive engineers. For Our Listeners Insurance Institue for Highway Safety: IIHS.org National Highway Traffic Safety Administration: NHTSA.gov Mazda USA

In this episode of The Founder Spirit, Barney Swan, Founder of ClimateForce, an explorer and a gifted keynote speaker, shares stories of planting trees with Dr. Jane Goodall, working with both modern and Indigenous wisdom keepers,  his approach to  mental health and wellbeing in navigating the “attention economy”.  In this conversation, Barney discusses the importance of self-realization and circular economy, honoring what has brought us this far, and how to find common ground on sustainability. He also explores the interconnectedness of biodiversity and the survival of human species, while emphasizing the need for commitment, humility, and humor in creating a safety net for the future. How do we navigate the attention economy and find common ground on sustainability?  TUNE IN to this conversation & find out. For detailed transcript and show notes, please visit TheFounderSpirit.com.Also follow us on: - LinkedIn: https://www.linkedin.com/company/TheFounderSpirit- Instagram:  https://www.instagram.com/TheFounderSpirit- YouTube:  https://www.youtube.com/@TheFounderSpirit- Facebook:  https://www.facebook.com/TheFounderSpirit- X:  https://twitter.com/founder_spiritIf this podcast has been beneficial or valuable to you, feel free to become a patron and support us on Patreon.com, that is P-A-T-R-E-O-N.com/TheFounderSpirit.As always, you can find us on Apple, YouTube and Spotify, as well as social media and our website at TheFounderSpirit.com.The Founder Spirit podcast is proud to be a partner of the Villars Institute, a non-profit foundation focused on accelerating the transition to a net-zero economy and restoring planetary health.About This Podcast:Whether you are an entrepreneur, a mid-career professional or someone who's just starting out in life, The Founder Spirit podcast is for you!In this podcast series, we'll be interviewing exceptional individuals from all over the world with the founder spirit, ranging from social entrepreneurs, tech founders, to philanthropists, elite athletes, and more. Together, we'll uncover not only how they manage to succeed in face of multiple challenges, but also who they are as people and their human story.So TUNE IN & be inspired by stories from their life journey!

Professor Rohit Srivastava shares his vision of transforming India through a 10X innovation mindset, prioritizing patents over papers, and building product-focused ecosystems that turn academic research into market solutions.5-point Episode SummaryThe 10X Impact Framework: Prof. Srivastava's approach to creating 10 times more value through patents, startups, and reaching more patients than conventional academic labs.Patents Over Papers: How filing 250+ patents and co-founding 15 startups is transforming academic research into market solutions for India.Building Innovation Ecosystems: Creating bio-clusters across India to connect universities and accelerate product development through interdisciplinary collaboration.Product-First Thinking: Training students to identify market needs and develop solutions that can reduce India's ₹90,000 crore medical device import bill.From Innovation to Impact: The vision to create thousands of "innovation builders" who will transform India from a service economy to a product powerhouse by 2047.Timestamps00:03:37 - 00:05:56 Mentors Who Shaped My Vision for India 00:05:56 - 00:08:55 India's Forward-Thinking Academic Leaders 00:08:55 - 00:11:47 Making Maximum Impact with Minimum Resources00:11:47 - 00:15:00 Patents vs Papers: The Future of Innovation 00:15:00 - 00:18:03 Why Product-First Thinking Changes Everything 00:18:03 - 00:21:39 The Product-First Mindset Behind Innovation 00:21:39 - 00:25:25 The 10X Impact Framework for Success 00:25:25 - 00:28:47 Building NanoBIOS - an Innovation Ecosystem in Academia 00:28:47 - 00:35:02 Transforming Students into Innovators 00:35:02 - 00:38:52 Why Interdisciplinary Thinking Creates Better Products 00:38:52 - 00:42:04 Cross-Pollinating Innovation with Bioclusters Across Universities00:42:04 - 00:45:02 How Patents Create a Virtuous Cycle of Innovation 00:45:02 - 00:49:08 Advice for Young Academics: Be Innovation Builders 00:49:08 - 00:49:43 Can India Create Its Own Philips or Siemens? 00:49:43 - 00:50:08 What is Success? 00:50:08 - 00:50:29 Advice for 18-Year-Olds in University Today 00:50:29 - 00:51:01 The Best Advice I've Ever Received 00:51:01 - 00:51:54 My Dream Dinner with Innovation Giants 00:51:54 - 00:52:27 The 10X Thinking That People Find Hard to AcceptSelected Links and Show NotesSubscribe to our Weekly NewsletterAbout Prof. Rohit SrivastavaProfessor Rohit Srivastava is a pioneering academic entrepreneur who holds the Himanshu Patel Chair at IIT Bombay's Department of Biosciences and Bioengineering. Known for his revolutionary "10X impact" philosophy and "patents over papers" approach, he has filed over 250 patents and co-founded more than 15 startups in just 19 years. His Nanobios Lab has commercialized numerous affordable medical technologies including UChek (a mobile urine analysis system) and Suchek (an indigenous low-cost glucometer), helping reduce India's dependence on imported medical devices.Honored with the prestigious Shanti Swarup Bhatnagar Prize (2021) and the inaugural Vigyan Shri Award (2024), Prof. Srivastava is transforming how academic research translates to market solutions. This episode was made possible by the great folks at Effortless.Effortless has been designed to be user-friendly, aiding you in your journey to streamline financial tasks. Experience the convenience of achieving e-Invoicing and E-way Bill Generation in just a couple of clicks, simplifying your business processes.#10xImpact, #InnovationIndia, #PatentsOverPapers, #ProductFirstThinking, #StartupEcosystem, #MedicalInnovation, #MakeInIndia, #FrugalInnovation, #IITBombay, #HealthTech, #BioTech, #AcademicEntrepreneurship, #IndianInnovation, #ViksitBharat, #TechForHealth

Hydrogen has great potential for helping society to reach net-zero emissions.  The problem is that the most economical and established production methods for hydrogen depend heavily on fossil fuels and result in roughly a dozen kilograms of carbon dioxide emissions for every kilogram of hydrogen produced. The carbon-free way to produce hydrogen is by splitting […]

Can bioengineering improve the health, vitality, and longevity of human beings? What would the future look like if the medical system were about preserving health rather than just treating symptoms? In this episode, Kevin Caldwell, the CEO, Co-Founder, and President of Ossium Health, sits down to share his thoughts… Ossium Health is a commercial-stage bioengineering company that uses its exclusive organ donor bone marrow banking platform to develop stem cell therapies for patients suffering from life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Initially built from a small startup, it evolved into the clinical-stage bioengineering company it is today with one primary mission: To improve human health through bioengineering. Join the conversation now to explore: How Kevin's mindset shift in business led to the creation of Ossium.  Why the healthcare system isn't adequately equipped to deal with modern chronic diseases.  Types of cell therapies that provide relief for patients with blood and immune conditions. The role that cell composition plays in the reactivity between donors and recipients.  Before founding Ossium, Kevin worked as an Engagement Manager at McKinsey's San Francisco office, where he advised clients in the biotechnology and healthcare industries. His projects spanned from conducting due diligence on biotech startup acquisitions to restructuring financially distressed biopharma companies. Over the course of his tenure, Kevin led more than 20 engagements for over a dozen clients, guiding teams in strategies for revenue growth, market-entry, and organizational restructuring. To learn about Kevin's cutting-edge work with Ossium Health, visit their website now! Episode also available on Apple Podcasts: https://apple.co/30PvU9C Boost Your Brainpower with 15% OFF!  Fuel your mind with BrainSupreme Supplements and unlock your full potential. Get 15% OFF your order now using this exclusive link: brainsupreme.co/discount/findinggenius Hurry—your brain deserves the best!

(2:30) - AI-designed proteins neutralise snake toxinsThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about how AI is being used to expedite the drug development discovery phase! Hint: it's a great primer for this episode :) Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

Advancements in arrhythmia care are transforming patient outcomes and reshaping clinical practices. Join Dr. Sanjiv Narayan, Professor of Medicine at Stanford University, and Dr. Paul Wang, Professor of Medicine and of Bioengineering at Stanford University, as they explore the evolving field of electrophysiology, highlighting the importance of early detection and best practices in the management of common electrical abnormalities. Discover how a patient-centered approach can enhance care and outcomes for those with irregular heart rhythms. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode99 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3229

From 2019: Bioengineering Innovation Outreach Challenge 2019 prize winners by Ian Woolf, Professor Hala Zrieqat talks about the ARC Bioengineering Innovation Centre, Dr Gavinda Singh talks about his research in cancer cures and his mentorship, Team Team from Sydney Girls High School talk about their Epilepsy brainwave monitoring solution, Team Biochis from Mount Carmel Catholic School talk about their nutritional deficiency detecting watch, Team Discovery Channel from Fort St High School talk about implanting an epinephrine dispensor for allergic shock, PhD students Mathilde Longfield and Ben Ferguson talk about mentoring the high school students, Team Exothermics from Sydney Girls High School talks about making scorpion antivenom cheaper and easier to access, Team Tissue Box from Sydney Girls High School talks about her team's water-proof hearing aid. Hosted and produced by Ian Woolf Support Diffusion by making a contribution Team Exothermics from Sydney Girls High School Support Diffusion by buying Merchandise

Brought to you by TogetherLetters & Edgewise!In this episode: Trump administration says it has no plans to fulfill $400 million 'armored Tesla' contractAnyone Can Push Updates to the DOGE.gov WebsiteDOGE Exposes Once-Secret Government Networks, Making Cyber-Espionage Easier than Ever White Hat Hackers Expose Iridium Satellite Security Flaws - Users' locations and texts can be intercepted, including DoD employeesHumane's AI Pin is dead, as HP buys startup's assets for $116MAll of Humane's AI pins will stop working in 10 days​​Elizabeth Holmes Breaks Her Silence in First Interview from Prison: 'It's Been Hell and Torture'​​Bioengineering makes robotic limbs feel naturalThe 20 year old PSP can now connect to WPA2 Wifi NetworkSpotify Weighs $6 Premium for Added Features, Access to TicketsApple unveils cheaper iPhone 16e powerful enough to run AIResearchers link a gene to the emergence of spoken languageWeird and Wacky: That guy who threw away $775 million in Bitcoin wants to buy the whole garbage dumpA humpback whale briefly swallows kayaker in Chilean Patagonia — and it's all captured on cameraWild fish can recognize human diversTech Rec:Sanjay - AutoSlashAdam - Tactical PenFind us here:

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Welcome to Stanford Engineering's The Future of Everything, the podcast that delves into groundbreaking research and innovations that are shaping the world and inventing the future. The University has a long history of doing work to positively impact the world and it's a joy to share about the people who are doing this work, what motivates them, and how their work is creating a better future for everybody. Join us every Friday for new episodes featuring insightful conversations with Stanford faculty and to discover how Stanford's research is transforming tomorrow's world. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Karen Christman, Sheila Chari, Stella Hurtley, and Robert Stephenson explore academic publishing in stem cell research, focusing on reproducibility, collaboration, and public communication. Editors from top journals discuss curating impactful research, sharing clinical trial data, and addressing challenges in scaling and standardizing therapies. They emphasize bridging silos, advancing precision regenerative medicine, and navigating open access publishing to responsibly propel the field forward. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39940]

Guest: Shalini Prasad, PhD Guest: Sriram Muthukumar, PhD Host: Charles Turck, PharmD, BCPS, BCCCP With the constant ups and downs of inflammatory bowel disease (IBD), consistent monitoring can help provide patient-centric care. Dr. Shalini Prasad and Dr. Sriram Muthukumar, co-founders of EnLiSense, join GI Insights to discuss the wearable device they developed to track inflammation markers in IBD patients. Dr. Prasad is the Head of the Department of Bioengineering at the University of Texas at Dallas, and Dr. Muthukumar is the CEO of EnLiSense.

Plastics can stay around for ages after being discarded. Han Xiao, director of SynthX Center and associate professor within the department of chemistry at Rice University, discusses a possible solution. Han Xiao serves as the Director of the SynthX Center and holds the position of Associate Professor within the Department of Chemistry, Biosciences, and Bioengineering […]

Freedom Broadcastersl Livestream OnJanuary 23, 2025, Thursday 12:00 PM EST Guest: Clifford Carnicom Topic: “Unveiling the Web: Bioengineering, Vaccines, and the Mystery of Morgellons” https://carnicominstitute.org/ https://carnicominstitute.substack.com/ Bio: Clifford Carnicom is the founder of the Carnicom Institute, a nonprofit organization dedicated to researching bioengineering, environmental health, and emerging diseases like Morgellons. With a background in environmental science and technical fields, Carnicom has spent decades uncovering the links between atmospheric aerosols, public health, and systemic challenges to scientific transparency. His work aims to promote awareness and understanding of complex issues affecting humanity and the planet. What we Discussed: - What Should the public be aware of whats in the chemtrails ( 22 mins) - What successes have been seen and who is behind this ( 30 min) - The budget of all the major organisations and what they do with the money (43 mins) - We do not have time to convince people (47:30 mins) - The attention of the World is on the wrong thing (51 min) - Does he have hope and does he see results ( 53 mins) - Should we be worried about the current Fogs (54 mins to 1hr ) - The eco system is being effected ( 1 hr) - The plan is to take pictures of the chemtrails see around the world ( 1 hr 7 mins) - Not all Apps not showing the flights of Chemtrails ( 1 hr 14 mins) - Serbia weather also effected ( 1 hr 17 mins) Creator Host: Grace Asagra, RN MA Podcast: Quantum Nursehttps://www.quantumnurse.life/ SpecialGuest Host: Atty David Meiswinklehttps://nationalarm.org/ SpecialGuest Host: Drago Bosnic BRICS portal(infobrics.org)https://t.me/CerFunhouse Co-host:Roy Coughlan Podcast: AWAKENING https://www.awakeningpodcast.org/

Imagine a future in which Band-Aids talk to your cells, pacemakers are powered by light and your gut microbiome gets a tune-up—all thanks to tiny bioelectric devices. Sounds like sci-fi, right? Think again. Prof. Bozhi Tian of the University of Chicago is on the frontier of bioelectronics, building living machines that can heal, enhance and maybe even transform what it means to be human. In this episode, he explains his research lab's work and explores the thrilling, strange and sometimes unsettling world in which biology meets technology.

Quantum Nurse http://graceasagra.bio.link/ presents Freedom International Livestream On January 23, 2025, Thursday 12:00 PM EST Guest: Clifford Carnicom Topic: “Unveiling the Web: Bioengineering, Vaccines, and the Mystery of Morgellons” https://carnicominstitute.org/  https://carnicominstitute.substack.com/ Bio: Clifford Carnicom is the founder of the Carnicom Institute, a nonprofit organization dedicated to researching bioengineering, environmental health, and emerging diseases like Morgellons. With a background in environmental science and technical fields, Carnicom has spent decades uncovering the links between atmospheric aerosols, public health, and systemic challenges to scientific transparency. His work aims to promote awareness and understanding of complex issues affecting humanity and the planet. Creator Host: Grace Asagra, RN MA  Podcast:  Quantum Nurse: Out of the Rabbit Hole from Stress to Bliss  http://graceasagra.bio.link/ https://www.quantumnurse.life/ Bichute https://www.bitchute.com/channel/nDjE6Ciyg0ED/ TIP/DONATE LINK for Grace Asagra @ Quantum Nurse Podcast https://patron.podbean.com/QuantumNurse https://www.paypal.com/donate/?hosted_button_id=FHUXTQVAVJDPU Venmo - @Grace-Asagra 609-203-5854  WELLNESS RESOURCES • Optimal Health and Wellness with Grace Virtual Dispensary Link (Designs for Health)    2https://www.designsforhealth.com/u/optimalhealthwellness • Quantum Nurse Eternal Health (Face Skin Care, Protein Powder and Elderberry) https://www.quantumnurseeternalhealth.com/ Special Guest Host: Atty David Meiswinkle https://nationalarm.org/ Special Guest Host: Drago Bosnic BRICS portal (infobrics.org) https://t.me/CerFunhouse Co-host: Roy Coughlan Podcast: AWAKENING https://www.awakeningpodcast.org/  

In this episode of HealthiHer, Dr. Brenner is joined by guest Dr. Kerry Reller, MD, MS, to uncover the surprising benefits of Semaglutide: beyond weight loss. While Semaglutide has gained popularity as a breakthrough treatment for obesity and type 2 diabetes, emerging research reveals its remarkable potential in addressing a variety of health challenges. From improving cardiovascular health and reducing the risks of heart disease to alleviating conditions like sleep apnea, this therapy is proving to be a game-changer in many ways few expected. In this episode, Dr. Brenner and Dr. Reller delve into: How Semaglutide works in the body and its broader therapeutic potential. The impact of GLP-1 medications on cardiovascular outcomes and disease prevention. Semaglutide's surprising role in improving sleep apnea and quality of life. Insights into how this treatment could shape the future of women's health and beyond. Whether you're curious about the science behind GLP-1s, seeking alternative ways to improve your health, or simply interested in the latest breakthroughs in medicine, this episode is packed with expert advice and actionable insights. Join us for this enlightening discussion that highlight the surprising benefits of Semaglutide: beyond weight loss and how it is redefining health care and transforming lives in unexpected ways! Is Semaglutide right for you? Take our quiz to find out – like and subscribe!  Instagram- https://www.instagram.com/amybrennermd/ Facebook- https://www.facebook.com/DoctorAmyBrenner YouTube- https://www.youtube.com/c/AmyBrennerMD Special Guest –Kerry Reller, MD, MS Dr. Kerry Reller is board certified in Family and Community Medicine and Obesity Medicine and works at Clearwater Family Medicine and Allergy in Clearwater and Palm Harbor, FL.  She completed her BS in Electrical Engineering from the University of Notre Dame and MS at Georgia Tech focusing in Bioengineering.  While working in systems engineering at a defense contractor, she realized she was not utilizing her skills and passion to help others.  She resigned from her engineering job and completed premedical requirements at The Johns Hopkins University, medical school and residency at the University of Maryland in Family Medicine.  She moved back to Florida to join her father in practice and to learn the clinical practices of Allergy, Asthma, and Immunology. She started her own family practice in July 2017 in addition to seeing allergy patients.   Dr. Reller later found her passion and completed board certification in Obesity Medicine. Find Kerry Reller, MD: website: www.clearwaterfamilymedicine.health Instagram: @clearwaterfamilymedicine Facebook: Clearwater Family Medicine & Allergy YouTube: @kerryrellermd TikTok: Kerryrellermd Podcast: Get Healthy Tampa Bay Checkout Dr. Reller’s podcast featuring Dr. Brenner 

This week on Data in Biotech, we welcome Timothy Jenkins, the Head of Data Science and Associate Professor at DTU Bioengineering, a leading scientific community dedicated to advancing areas of biotechnology, food technology, and health through innovative teaching and research.  Timothy starts the conversation by walking us through his background and early career beginnings, from the first time he expressed interest in zoology and venomous snakes to now leading a research group focused on AI-guided drug discovery for snake antivenom. He and our host, Ross Katz, dive into one of DTU's most exciting recent publications about "de novo" designed proteins to neutralize lethal snake venom toxins.  Inspired by Nobel Prize winner David Baker's groundbreaking paper and in collaboration with the Baker Lab on computational design methodology, this project holds great promise in therapeutic discovery and drug development. Tim explains how computational protein design and protein structure prediction are revolutionizing his field, highlighting compelling examples and milestones from his research on antivenom. He also provides an overview of the process used to discover new antivenoms, including the sourcing of biological data, model training, and integration of experimental feedback. Finally, we get Tim's perspective on the future of AI-powered therapeutic discovery, and his take on the integration of quantum computing into protein design. Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in the life sciences. Useful Links Nature - De novo designed proteins neutralize lethal snake venom toxins Timothy's LinkedIn DTU Bioengineering Website UW Institute for Protein Design “de novo” designed proteins project Information on Nobel Prize winner David Baker

Skip the Queue is brought to you by Rubber Cheese, a digital agency that builds remarkable systems and websites for attractions that helps them increase their visitor numbers. Your host is Paul Marden.If you like what you hear, you can subscribe on iTunes, Spotify, and all the usual channels by searching Skip the Queue or visit our website SkiptheQueue.fm.If you've enjoyed this podcast, please leave us a five star review, it really helps others find us. And remember to follow us on Twitter  or Bluesky for your chance to win the books that have been mentioned in this podcast.Competition ends on 22nd January 2025. The winner will be contacted via Twitter or Bluesky.  Show references:https://litlablondon.wixsite.com/lit-laboratoryhttps://www.instagram.com/litlablondon/https://www.threads.net/@litlablondonhttps://www.linkedin.com/company/litlablondon/https://www.facebook.com/people/The-Lit-Lab/100090991921959/ Abi Fafolu has a Master's degree in Bioengineering from Imperial College, and over 7 years' experience in public engagement with science. She spent her early career in science engagement, including on the Science Desk of The Guardian Observer and promoting open-access publishing at the European Medical Journal and Springer Nature.Since joining the UK government in 2015, she's worked in strategy, policy and programmes across four government departments including the Office of the Government's Chief Scientific Advisor, Lord Patrick Valance, upholding the role of science and evidence in decision making, and promoting developments in science as a Press Officer to the UK Science Minister. Abi is currently a government policy and strategy maker, and runs the Lit Laboratory (Lab), a "Science and Sip” experience reconnecting underrepresented audiences aged 21 to 40 with science. Transcription:  Paul Marden:  Welcome to Skip the Queue. A podcast for people working in and working with visitor attractions. I'm your host, Paul Marden. Paul Marden:  In today's episode I'm joined by Abi Fafolu, Founder of The Lit Lab. Abi has a Master's degree in Bioengineering from Imperial College, and over 7 years' experience in public engagement with science.Since joining the UK government in 2015, she's worked in strategy, policy and programmes across four government departments. She currently a government policy and strategy maker, and runs the Lit Laboratory, a "Science and Sip” experience reconnecting underrepresented audiences aged 21 to 40 with science.Unfortunately the internet wasn't kind to us when we recorded this conversation, and so the audio quality isn't great, but the conversation definitely was.Paul Marden:Welcome, Abi. Welcome to Skip the Queue.Abi Fafolu: Thanks, Paul. Thanks for having me. Paul Marden: Lovely to have you. Today's a little bit weird because we're recording this just before Christmas, but it's not actually going to go out until the new year. So what I'm going to say is happy New Year to you. I hope you've had a lovely Christmas, but the reality is we haven't had it yet. So strange. Abi Fafolu: Thank you and likewise. Paul Marden:So we always start our interviews with some icebreaker questions which you're never prepared for. So here goes nothing. I've got a couple for you. I think they're quite nice ones actually. What's your go to coffee order when you go to a coffee shop of your choice? Abi Fafolu: Embarrassingly, I saw a skit about this recently where I thought that I had a unique choice, but clearly I've been very moth by the Internet. It is a skinny flat white and the skit that I saw actually was people ordering hot chocolate, which has gone extinct in coffee shops. I think there were a few people doing kind of hot chocolate watching. They were seeing where the people would order hot chocolates and have the binoculars out to watch those people as they made that rare order in the shop. But no, mine is very common. It's a skinny flat white. Paul Marden: Yeah. So mine is just a normal straight up flat white. No nonsense, no fuss, just give me coffee. I just want a nice coffee. My daughter, her order, she's only 11, but she's taken to iced hot chocolate. But what do you call it? Is it iced chocolate like an iced coffee or is it iced hot chocolate? I always stumble over the order and it's never up on the menu. So I always feel a bit awkward asking for whatever it is that she wants. Abi Fafolu: I like that. Paul Marden: Yeah. Okay, next one. What animal do you think best represents your personality? Abi Fafolu: Oh, gosh, I'm probably like a reliable owl or something like that. Yeah. Kind of cosy in my tree when I feel like it, being a bit nosy and flying out to have a look at what's going on. Paul Marden: And every now and again savage on little animals. Abi Fafolu: Oh. I mean, maybe a bit of that, probably. But yeah, I think something like that. Paul Marden: Okay. I think mine would have to be one of those, one of those dogs that is really annoying and full of energy because I'm just, I'm always at like full power. I'm one of two extremes. I'm going full at it. Yeah, I'm just zonked out, shattered at the end. Yeah. Abi Fafolu: Okay. Paul Marden: So I'd probably be like a springer spaniel where loads of walking is necessary to get rid of all the energy. Otherwise I'll be really annoyed.Abi Fafolu: Got you. A little dog who doesn't know that they're little and springs out into the world. Paul Marden:I'm sure there's something Freudian about that. I'm not sure. So we are talking a little bit about your project called the Lit Lab today which as listeners will know I always have a little chat with people before we do the interview and you know, I'm really interested in this concept, the tagline that you talked about which was the idea of getting adults to drink in a Science lab. We first met at the Association of Science and Discovery Centres and you know, we had a lovely conversation whilst were at the ASDC conference and I found out a little bit more about Lit Lab. But I think before we get to that point let's just talk a little bit about you and your background. So tell us about you. Tell us about your background and maybe a little bit about day job. Abi Fafolu: Yes, of course. So I am a Scientist by training. I have a Master's degree in Bioengineering from Imperial College and about 7 years experience in public engagement with Science. So that has looked like working on the Science desk of the observer newspaper, publishing medical research at Spring and Nature, working with the Chief Scientific Advisor and in government and with the Science Minister as well doing kind of comms and press releases. At the moment I work in strategies by working thinking about where my organisation wants to get to and how we do that. And for me I think it probably brings together a lot of the skills and interests I have. Abi Fafolu: It's really about kind of seeing that bigger picture and wondering how things come together and wondering what things will be different and kind of looking at the evidence and friends and things that are going on that help to paint a picture actually of kind of what the options are and gives you a sense of what's possible. So I think there's a thread really through my kind of career history which is a lot about being nosy and having that kind of owl sand view of the world. And yeah, I think my kind of interest and passion in and Science has also kind of given me a lot as well in the subject and things that have piqued my interest. Paul Marden: I think it's such an interesting opportunity for you to being in public policy and Science within government over the last few years. It's a really interesting perspective and it's the kind of career that no kid at school would ever dream is a career. Yeah. You know, kids at school can imagine being a chemist or a biologist, they can relate to that. But the idea that Science exists at the heart of government and influences everything the government does is not something that your average kid would think about doing. So how do you end up falling into a role like that? Abi Fafolu: Yeah, well, I mean, I suppose my reflection on what you've just said is sort of. So I think for me, you know, I'm currently the only person in my network who has a background in Science, so I didn't really have a clear picture of what it would look like to be a Lab Scientist. You know, you do those practicals at school, you meet teachers and, you know, lab assistants who are, you know, models of that for you. But I didn't know anyone that did that sort of work and I wasn't sure if I was good at it. I just knew that I enjoyed it. Abi Fafolu: And I think when I stumbled across the idea that actually there's a whole strand of Science that's about communicating with people, what's going on, about bridging that gap, really, between the doing and the using of Science, that, for me, opened up a whole new world. And a lot of the kind of journey I suppose I've been on in my career is thinking about how to really help people see the impact of the Science in their everyday life. So I think, you know, in publishing, you're at the forefront of all the developments, you see everything that's going on and it's really interesting. But the average person on the street, you know, has no idea how to apply bioengineering techniques that are, you know, novel and coming out of the lab for their everyday life. Abi Fafolu: But then when we have a situation like Covid, where we're starting to look for novel ways to make vaccines, you know, that's the sort of application, I suppose, of the work that people are doing and the interest that drives them. So for me, I think following that curiosity into this kind of world of Science engagement has been a bit of a journey. Paul Marden: So that leads nicely to the association of Science and Discovery Centres, how we met at their conference. There was a lot of talk at the conference, wasn't there, about public engagement? How do we enrich people's lives with Science and help people to feel that Science is part of their them and that they can influence the Science decision making and the direction that Science takes over the next decades. You're a trustee of ASDC, so what does that involve? Abi Fafolu: Yeah, you've said it really. But ASDC's mission is absolutely that, to make Science accessible and inclusive for more people and to be seen as a valuable part of everyday life. So their role broadly is to kind of bring together and support Science engagement centres, discovery centres and other spaces like that together. And I know you've had probably doing a wonderful job of explaining what ASDC does and the value it brings. I won't go too much into that, but as a trustee, I suppose the core of that role is to give support and challenge to the CEO. I suppose you think of it as, you know, a CEO doesn't really have colleagues or peers and so, you know, we're head trusted advisors in her, in this case. Shaaron ASDC. Abi Fafolu: We are the people that help the sense tech decisions and make sure the organisation is living up to its purpose. Paul Marden: Absolutely. So that's a little bit of background. Let's talk about the Lit Lab. Explain to our listeners who know nothing about the Lit Lab. What is it? Let's start with the broad picture of what it does. Abi Fafolu: Yeah, yeah, sure. So the Lit Lab is the UK's first Science and bit. It is a laboratory or Science themed social event where people do fun homestyle Science experiments, make drinks and take part in kind of friendly challenges. It's a social event that is something I do alongside my day job, as I mentioned. And so it runs quarterly at the moment. But essentially people arrive or kind of pop up Science lab, usually in the basement of a bar or a pub. We've done bigger venues like box parking spaces like that as well. But when they arrive they will find kind of their own lab coat and goggles waiting for them. They might get a drink at the bar while they settle in and then we have a host and lab assistant who will walk them through three experiments and two games. Abi Fafolu: So we always start with a drink, we make a drink. We call that our kind of molecular mythology series. So anything from kind of dry ice cocktails, cool kind of layered drinks and then we end with an explosion. So yeah, some of our more popular ones tend to be ones that involve a bit of cleanup at the end. So that's kind of the model for the event and it's really about helping adults to reconnect with Science and have a good time doing it. Paul Marden: Excellent. So you're taking this out into pubs and bars. It sounds like a Science centre in the back of a van or something. So what sort of kit are you taking with you into the event spaces? Abi Fafolu: Yeah, I mean you're not far off with the kind of back of a van analogy. I have a garage full of labware.  But my neighbours always look at me a bit suspiciously when I start to pile up my pipettes and bits of lab coats and that sort of thing. Paul Marden: Awkward conversations with the neighbours as they're watching what you're taking out the garage. Abi Fafolu: I mean, if I suddenly see flashing lights at my door, I'll probably have a sense and someone's got the wrong end of the stick. But no, we, as I said, you know, kind of a small pop up and so really it's a startup and it's got all of the kind of all that comes with that. So, you know, storing lots of kit in my garage means that the event is intimate because there's only so much, you know, test tubes and beepers and chronicle class I can fit in one space. And then we're on the day, kind of a group of lab assistants and me who will set up the stations for guests. So, you know, for different experiments where we're really trying to replicate, you know, the type of materials and tools that you would use to explore the same sort of things. Abi Fafolu: So one of the things that we do in the lab is DNA extraction with home style ingredients, things that you can find in your skin do with skids. But we're using, you know, conical glass and pipettes and syringes so that we're really being accurate with our measurements and people have that chance to get stuck in. Abi Fafolu: But we don't do any tutorials. It's not, it's not a lesson. It's really for people to get hands on and try things out for themselves. So we give them a QR code that they scan for instructions and it will tell them kind of what the stats are. But you can take that all either, you know, you've got all this in front of you and if you want to mix some things together and see how it goes, then that's the, you know, that's the spirit of Science. They're more than happy for people to do that too. Paul Marden: Excellent. So where did the idea come from? How did, how did you come up with the idea for the lit lab? Abi Fafolu: So it's like a lot of people thinking about kind of, you know, what they want to do with themselves and kind of what skills they have and things they're passionate about. Particularly kind of post lockdown where, you know, you had a lot of time to reflect and think about whether you were making the most of, you know, your skills and abilities. I was seeing a lot of kind of social events come out that were particularly focused around sort of activities. People, I think, wanting a bit more purpose as well when they do leave the house, because that was a luxury. We didn't take for granted that when we step out, we're spending time and that means so much. So a lot of activities that people were doing were things like pains and sips. Abi Fafolu: So this is the model, really, that I've reprised, where people buy tickets to an event and they create art and have drinks and really, it's a model that's really growing globally. So I think that the market in America is in the millions, if not billions, as a kind of global event concept, and definitely picking up here as well, but you see it kind of taking off in different formats. So there are pottery and sips and D Day and sips and all sorts of things like this. And so for me, I kind of. I looked at that and I thought, I think I should do something like this, too. And so I spoke to kind of friends and family and I said, I kind of wanted to try out this thing. I think I could make something similar here. Abi Fafolu: And so I got together a group of friends at my mum's church hall, bought some lab coats from Amazon and spent absolutely ages writing loads of Excel sheets about the experiments that we could do and what I need to buy to kind of get that together, and had them for far too long for an evening after work, doing all sorts of great experiments. And they loved it. Abi Fafolu: They thought it was. It was great and really fun. And so, yeah, it kind of took off from there. I thought, you know, this maybe might be something that we can bring to more people. And so since then, with, I think, about 300 guests, we've got, I think, sort of a thousand or so followers on social media. We've been in timeout London and Secret London magazines and that sort of thing. So, yeah, I think it's reaching some of the right people, but I think you could do more. Paul Marden: So for me, I think there's something about it that really attracts me. I'm an extroverted introvert, so I like to be around other people, but it can be challenging going into a new social situation. For me, I might not feel comfortable. What makes me feel comfortable is being in the context of having a shared mission with people. Paul Marden: So the idea of, you know, having these experiments to conduct with people, there's something to focus on rather than just the people that are around you. And you know, I need to speak to everybody. I need to be the life and soul of the party. No, no, I'm focusing on this thing. And the social element of just being with other people happens around you when it's done at its best because it's not taking all your conscious effort. Your conscious effort is focused on this thing that's in front of you. You and the rest of it is just blossoming around you. Abi Fafolu: So yeah, no, absolutely. I think the other part of that is that you're in a room with people with similar interests. Right. You're creating community. There are people there that are really excited and curious about kind of rekindling that passion that they had for Science or that interest that they had. And so there's a real energy of people kind of wanting to get stuck in and being excited kind of for every thing that we bring out. And yeah, it absolutely is, you know, part of my plan for it to be able to build a bigger community around it. And we have some of that online. Abi Fafolu: So there's a lab Patreon site where we share Science news, blogs about kind of running a pop up Science lab, you know, behind the scenes and really helping people to reconnect with Science, even if they're not in that space with people, but also just to find that community with that said interest. Paul Marden: So you come up with these spreadsheets at the beginning. You tracked all your mates in a church hall for the first evening. Was there a lot of experimentation involved in. I'm a meta level here. Yeah, experimentation around the experiments that you want to run. Were there some that you did that just weren't successful? Abi Fafolu: Oh yeah, absolutely. Yeah. So I do have a mega spreadsheet of kind of experiments like I could do a lot of the ones with fior. I've had to rule out the various disappointingly. But we'll see how we can get around that in future. But no, absolutely, there's the constraints of, you know, the idea of this is that a lot of the Science is home style and you could absolutely kind of go home and replicate that. One of the things that we do online is created tutorial videos used to try some of the experiments from the lab. And so what I don't want is to have to find kind of lab grade chemicals because that's not homestyle Science. Paul Marden: No. Abi Fafolu: And so I really want it to be accessible in the truest sense. And so that's a, you know, a philtre for me when it comes to thinking about what sorts of things we could do as much as possible as well. You know, having experiments that have real world kind of application or implication. I talked about the kind of DNA one, you know, the method that we use for that at home is really similar to what we do in the lab. It just has, you know, different types of reagents, you know, more specialised or more tailored to doing that. But yeah, I think being able to really kind of illustrate kind of core concepts in Science as well as do them with materials and things like that are accessible is a strong philtre for me. Abi Fafolu: But thinking about some of the ones, I suppose that haven't made the cut. And as I say that actually I should say that we do have a kind of core set of experiments as well as seasonal ones. So the most recent event was Halloween and we started by making blood transfusion cocktails. So we had blood bags with grenadine in them. We did a kind of gruesome DNA extraction with picking livers, we made potions that are wrapped to finish off the session, that sort of thing. But yeah, a lot of the ones that are kind of more temperamental, I guess, and not so resilient for people who are not going to read the instructions are the types that don't quite make it in. And they can be things like, you know, dry ice doesn't last forever, it eliminates, it evaporates quite quickly. Abi Fafolu: And so there are things like that where, you know, over the course of the kind of two hour event maybe is not the best type of experiment to try and do because by the end of it some people will still have dry ice and some people won't. And I'm not, you know, I'm not in a degree where I can, you know, just turn the corner and get some more. So yeah, some of them are just kind of practical, why they don't quite make the part. But yeah, definitely a longer list of things I try with more opportunities to do. Paul Marden: I talked a little bit about why it piques my interest. But who is the audience that you're seeing coming along to events? Abi Fafolu: Yeah, so I think both from kind of attendance at events and you know, the feedback that we get and the kind of data from that, but also our insights from social media and things like that. We can see that the audience is largely women. So about 70% women age between 21, maybe 45. Interest really in Science culture, trying new things, meeting new people. And I'm especially interested actually as well in targeting minority audiences. So the women, but also black and ethnic minority people who are underrepresented in Science, who maybe, you know, don't have access to Science and that sort of discourse and really just to change perceptions about who Science is for. So I think the idea that you can do Science outside of a classic setting, outside of a lab, outside of research, outside of academia is really important to me. Abi Fafolu: So, yeah, I think it's a broad audience and I think Science is absolutely for everyone. But part of my mission is also to make sure we're reaching some audiences who aren't really. Paul Marden: That's the audience. Are you doing, is this a solo effort for you or have you got teams of lab rats that come along and help you? Abi Fafolu: And so I'm a solo entrepreneur, I am the founder, one of those hats. But on the day of the event I do have a team, we call them lab assistants rather than lab rats. But I do have a team of people who are amazing at preparing the experiments. People so they can get stuck right in troubleshooting any kind of niggling issues, you know, with the experiments on the day and making sure that people kind of know what they're doing. And for me, actually it's been really important to open those opportunities up to up and coming Science communicators. So, you know, people who want that experience really in practising and engaging the public directly with Science. Abi Fafolu: And again, you know, there's nothing quite like this at the moment, so I'm hoping, you know, that's a good opportunity for them as well to kind of pick off those sorts of careers. Paul Marden: Yeah, it's quite nerve wracking, isn't it, doing what you're doing, stepping into a sector where. Or creating your own segment. Yes, you're taking inspiration from things that already exist, but nobody else is doing this. And you've got. It's at the core of being entrepreneurial, isn't it? You've got to test the market and experiment to see where it goes. But that can be quite nerve wracking. So having that team of lab assistants, those people that are helping you on the day, you know, it's invaluable because you can't have eyes in the back of your head when you're at the event, it's really, you know, it's really hard, I guess, to be able to run one of these events, keep it all flowing, solve the problems and be a gracious host at the same time. Abi Fafolu: Yeah, absolutely. And I should say, actually I'm not the host, so I am very much kind of in the background for the events themselves, they are hosted by. I have a few different people that kind of tap into this role, but essentially they're presenters and people whose job it is that have that sort of MC role to keep the crowd engaged and enthused. And again, like I said, they don't teach, they don't set out. Kind of made the story of what we're going to do, but they encourage and, you know, prod and make jokes with the group and that sort of thing. One of the elements of it that I think works well as well is that we try to introduce kind of competition. Abi Fafolu: So if we have, you know, two or three tables, depending where we're doing it, you know, each table is a group that competes and they choose a table name which is made up of a range of things that might be for that month, elements in the periodic table, their favourite horror movie and their favourite brand of alcohol. So they get kind of wacky table names and earn points as they go along. And we actually, for most events, compete for spots or fleets. So if you're a winning table, you'll find a rap of spots coming your way. So, yeah, it's definitely a social event I think we major on as well as Science in our event. Paul Marden: Of course, it does sound a little bit like a kind of classic Science communicator role at the Science Centre, doesn't it? You know, that job to engage people in Science. But you're hiding. You're hiding the vegetables, aren't you? They're learning a little bit about Science, but at the same time they're enjoying themselves and you've got to major on the enjoyment and engagement, otherwise they're never going to learn something. Abi Fafolu: Yeah, no, I absolutely agree with that. And we provide some of that background to people that want it. So, you know, in the same way that you can scan the QR and find out what the instructions are, you can also scan and find out kind of what the Science is behind what you're doing. Because I think, you know, if people are particularly curious, you want to make sure that they have the opportunity to follow up. Paul Marden: Yeah. So you're taking this out to pubs and bars. Have you got future plans to try other types of spaces or to take this to other places? Abi Fafolu: Yeah, so I know that you we're alluding to as well, the kind of theme of this. So, you know, absolutely, we're doing Science, but this is. This is culture, this is creativity, this is all of the things that, you know, make Science real and enjoyable for people as well. So Absolutely. I see it as a kind of creative cultural endeavour. I've done a few events in sort of different contexts. I, for example, was just running a winter fair event called University of East London. And that, I think, gives us the opportunity to have people kind of zip in and out from what we're doing and see it in the context of other things as well. And I think this brings to the forefront even more that, you know, this is something that's for entertainment. Abi Fafolu: You know, like, there's education here, that this is an entertainment concept. So, yeah, I think it really has a place in lots of different spaces and I think there's lots of opportunity, really, to see where it can go. Yeah, absolutely. Would love to work with different types of venues, so universities. But also there are these other cultural institutes, talking museums and places like that, where I think there could be a really nice partnership opportunities there. Paul Marden: Yeah, absolutely. There's an element of. And it was something that somebody said at the ASDC conference. It was one of the questions that got asked at the Skip the Queue episode was all about getting the A into STEAM. So getting. Getting the Art into STEAM. Subjects. There's an element of if you could take this into a bar and a pub, you can take this into art institutions, to galleries, to museums, other cultural institutions. All these sorts of institutions are looking for ways in which they can extend their reach, that they can. Can serve different audiences, generate revenue for themselves at times when the institution is quiet. And this is just a lovely concept to be able to pop the things in the back of the van and take it to institutions and help them to do those things. Abi Fafolu: Yeah, thank you. And I think, just to add to that, I think we're definitely seeing a rise of that with the kind of museum lakes. It's a theme across lots of different venues completely. And. And it's absolutely that. It's about the kind of adult market and recognising, I think that, you know, just because you're an adult doesn't mean that you can't still have fun with the things that you were interested in as a younger person or, you know, hobbies that you don't have the opportunity to do. So, yeah, Science is a hobby, definitely something I'm all the way behind. And I think the kind of adult space is a really good opportunity for that. Yeah. Paul Marden: Oh, completely. I get to masquerade behind my daughter. I'm taking her to Science centres for her benefit. But the reality is I have a whale of a time and I love going to the Science central, Science museum And I'd feel a bit odd going as a single bloke wandering around some of these institutions on your own during the daytime. It might not feel quite right. But a Science late event, I could totally, you know, I've done enough ASDC events at Science centres where we've had the evening meal in a Science centre in the evening and it's been delightful to wander around these places in the evenings. There's a huge amount of opportunity at your local Science centre to find things that engage adults as well as kids. Abi Fafolu: Yeah, absolutely. Paul Marden: What are your goals? Where do you want to take the Lit Lab for the future? Abi Fafolu: Yeah. So, I mean, again, this concept of kind of popping things in the van and kind of rocking up wherever is definitely a perk of the current model, but it still sort of means that at the moment, you know, the little ad is in London big as I am, you know, I don't want that to be a kind of barrier for it and I definitely don't want it to stop the right people from reaching it. So for me it would absolutely be that to be able to reach more parts of the country and particularly, you know, like the cities of culture. I'm thinking that, you know, the Bristols and the Manchesters and the Bradfords next year as the 2025 or this year. Paul Marden: That was slickly done. Well done. Abi Fafolu: Yeah, I think, you know, being able to meet people where they're already exploring these interests and then hopefully see that Philtre out as well would be wonderful. Paul Marden: Okay, so is that partnership model or is that a kind of a franchise model or are you open to conversations with people about how you could deliver this? Abi Fafolu: Yeah, no, absolutely open. I think that's, you know, a perk of being. Being the first, isn't it? But, yeah, all things are on the table and I think that's a wonderful thing. You know, I'm probably still in the. It's my baby face. I can imagine. I can imagine that there's probably a bit of hand holding that would. Would come before any. But yes, I think absolutely open. Paul Marden: Yeah, that's interesting. Well, look, it's been lovely talking to you, finding out a little bit more about you and finding out more about The Lit Lab. I think it's such a wonderful concept. I feel a team rubber cheese evening event coming along soon where I think we bring the team and we do a little bit of Science together. I think that might be a nice idea. Abi Fafolu: Idea more than welcome. I'd love that. Paul Marden: So we always ask our guests to give us a book recommendation. So Abi, what's your recommendation for the listeners today? Abi Fafolu: Yeah, I had a good think about this and you know, in all that I've talked about, I think there's probably also something about reclaiming this kind of nerd label. I think my recommendation is probably going to fall in that space, but I'm happy with that and I own it. But mine is in the genre of sort of mythology, magical realism, fantasy, and I really love Greek mythology. But I'm actually also getting into African mythology, of which there are loads of kind of classic but also kind of up and coming writers. And one that I'm really enjoying now is called She Would Be King by Wayétu Moore. And it's a story of basically the kind of creation of a new space in Liberia during the kind of transatlantic slave trade. Abi Fafolu: And it basically imagines the stories of the three different people in a sort of anthology way, who get powers as they go through the real horrible and inhumane kind of trials of, you know, being part of that. So from America to Jamaica to West Africa, you know, these three people go through different experiences of that and they all get powers that help them to cope with that. And it draws on the types of powers that you might see in African mythology. So it's a really beautiful book and a really inspiring and kind of educational one too. I think there's a lot of, you know, factor accuracy in terms of, you know, what happened and the types of experiences that people accounted. Yeah, that's one of my definite recommendations and I'm actually rereading it at the moment. Paul Marden: Wowzers, listeners. So if you'd like a copy of the book that Abi recommends, normally I'd say get over to X and repost the show announcement on X, but you can do that on bluesky now. So go find us. We are @skipthequeue.fm on Bluesky and do whatever you do to repost a notice on bluesky and say I want Abby's book. And the first person that does that will get a copy of Abi's book sent to them as a gift from us. And I'll be very excited because we'll have more followers on Bluesky. X is a bit of a dumpster fire now, so we are moving rapidly to Bluesky. Abi, it has been delightful to meet you. Paul Marden: If listeners would like to find out more about the Lit Lab, all of your links and your socials and the website will all be posted in the show notes. So listeners, you'll be able to go and find out about where the next Lit Lab events are all on Abi's website. It's been lovely to meet you. Thank you ever so much for coming on the podcast. Happy New Year. Abi Fafolu: Thank you so much. Paul. Thanks so much for having me. And Happy New Year to you too. Paul Marden: Thanks for listening to Skip the Queue. If you've enjoyed this podcast, please leave us a five star review. It really helps others find us. And remember to follow us on Twitter for your chance to win the books that have been mentioned. Skip The Queue is brought to you by Rubber Cheese, a digital agency that builds remarkable systems and websites for attractions that helps them increase their visitor numbers. You can find show notes and transcriptions from this episode and more over on our website, SkiptheQueue.fm. The 2024 Visitor Attraction Website Survey is now LIVE! Dive into groundbreaking benchmarks for the industryGain a better understanding of how to achieve the highest conversion ratesExplore the "why" behind visitor attraction site performanceLearn the impact of website optimisation and visitor engagement on conversion ratesUncover key steps to enhance user experience for greater conversionsDownload the 2024 Rubber Cheese Visitor Attraction Website Survey Report

The global onset of the coronavirus shut down schools, which interrupted the educational process for millions of students. The expectation was that deficits in fundamental areas would be made up once the world opened up again. Did that happen though? Amy and Mike invited education professional Nancy Weinstein to explore post-pandemic learning loss.  What are five things you will learn in this episode? Are students really performing differently since the pandemic?  Does learning loss differ based on age or gender? Were students in all parts of the United States equally impacted by the pandemic? How can students begin to repair pandemic learning gaps? What can parents, educators, and coaches do to repair pandemic learning loss? MEET OUR GUEST Nancy Weinstein founded Mindprint Learning with the perspectives of both a parent and an innovator.  Realizing a need to address a common challenge for parents and educators, she drew upon her background in science and business to create Mindprint, the first ever valid at-home cognitive assessment supported with next-step strategies for growth. Nancy has an extensive background in business, including work at Goldman Sachs, The Walt Disney Company Corporate Strategic Planning, Bristol Myers Squibb, and several smaller Internet companies. Nancy has an MBA from Harvard Business School with first year honors and a BS/BSE summa cum laude from the University of Pennsylvania and Wharton School of Management and Technology Program, Bioengineering and Finance. As a mother of two, Nancy recognizes the challenges parents face today, from helping with homework, to navigating the ever-changing pace of education and technology.  Nancy previously appeared on this podcast in episode 132 to discuss The Science of Memory. Find Nancy at https://mindprintlearning.com/. LINKS MindPrint Research Brief - Post Pandemic Brain Changes: Results from 35K Students Study Finds COVID Harmed Cognitive Skills of Students — and Teachers – The 74 RELATED EPISODES COVID LEARNING LOSS THE GROWING IMPACT OF CHEATING DURING COVID HOW TESTS AID MEMORY ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our past episodes on the show page and keep up with our future ones by subscribing to our email newsletter. ABOUT YOUR HOSTS Mike Bergin is the president of Chariot Learning and founder of TestBright. Amy Seeley is the president of Seeley Test Pros and LEAP. If you're interested in working with Mike and/or Amy for test preparation, training, or consulting, feel free to get in touch through our contact page.  

Are exosomes the planet's ultimate healing tool?! In this episode, Dave Asprey sits down with Harvard-trained physician Dr. Edward Park to explore the groundbreaking science of exosomes. Dr. Park, a pioneer in regenerative medicine and author of Exosomes: Songs of Healing, explains how these tiny cellular messengers are revolutionizing health and longevity by bypassing the limitations of stem cells. BUT this episode isn't just about cutting-edge science. Dr. Park also shares profound insights into life, resilience, and emotional well-being, offering advice that goes far beyond medicine. From the power of forgiveness to breaking free of limiting beliefs, his perspective blends science, spirituality, and practical wisdom for living a better life. Here's what you'll learn in this episode: • How exosomes work and why they're being called the future of regenerative medicine • The key differences between exosomes and stem cells—and which is better for healing • Real-life applications of exosome therapy for injuries, anti-aging, and overall health • The potential of exosomes to enhance brain function, reduce inflammation, and promote recovery • Dr. Park's advice on emotional resilience, gratitude, and creating lasting change With over a decade of experience, Dr. Park shares compelling case studies, cutting-edge insights, and practical advice for anyone looking to upgrade their body, mind, and life. Whether you're managing chronic pain, exploring anti-aging therapies, or seeking wisdom for navigating life's challenges, this episode has something for everyone. Sponsors TRU KAVA | Go to https://trukava.com and enter code DAVE15 at checkout for 15% off Resources: • 2025 Biohacking Conference – https://biohackingconference.com/2025 • Dr. Edward Park's Website: Recharge Biomedical – https://www.rechargebiomedical.com • Dr. Edward Park's Book: Exosomes: Songs of Healing – https://www.amazon.com/EXOSOMES-Songs-Healing-Ed-Park/dp/098260632X • Dr. Edward Park's YouTube Channel – https://www.youtube.com/channel/UCpp9DlRArB1rKAWNwoouiTg • Dr. Edward Park on Instagram – https://www.instagram.com/dredpark/ • Dave Asprey's Website – https://daveasprey.com • Dave Asprey's Book: Smarter Not Harder – https://daveasprey.com/books • Danger Coffee – https://dangercoffee.com • Danger Coffee Instagram – https://www.instagram.com/dangercoffeeofficial/ • Dave Asprey's Linktree – https://linktr.ee/daveasprey • Upgrade Collective: Join The Human Upgrade Podcast Live – https://www.ourupgradecollective.com • Own an Upgrade Labs – https://ownanupgradelabs.com • Upgrade Labs – https://upgradelabs.com • 40 Years of Zen – Neurofeedback training for advanced cognitive enhancement – https://40yearsofzen.com Timestamps: • 00:00 Introduction to Exosomes and Healing • 00:48 Understanding Exosomes: Stem Cell Communication • 01:19 Dr. Edward Park's Insights on Exosomes • 02:47 Exosomes vs. Traditional Treatments • 04:44 Exosomes in Regenerative Medicine • 07:33 Cost-Effective Regeneration Protocols • 12:35 Exosomes for Hair Growth • 14:37 Stem Cells and Brain Health • 25:33 Banking Stem Cells for Future Use • 35:27 Epigenetic Age and Longevity Predictors • 37:48 CRISPR and Gene Editing: Risks and Benefits • 39:43 Basic Health Tips for Longevity • 41:02 Spirituality, Past Lives, and Healing • 42:50 Questioning Medical and Political Narratives • 47:54 The Importance of Free Speech • 01:07:40 The Role of Intuition in Medicine • 01:09:22 Conclusion and Final Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.